TY - JOUR
T1 - Three-Dimensional Bioprinting and Its Potential in the Field of Articular Cartilage Regeneration
AU - Mouser, Vivian H.M.
AU - Levato, Riccardo
AU - Bonassar, Lawrence J.
AU - D’Lima, Darryl D.
AU - Grande, Daniel A.
AU - Klein, Travis J.
AU - Saris, Daniel B.F.
AU - Zenobi-Wong, Marcy
AU - Gawlitta, Debby
AU - Malda, Jos
N1 - Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: V. H. M. Mouser and J. Malda received funding from the European Community’s Seventh Framework Programme (FP7/2007-2013) under Grant Agreement No. 309962 (HydroZONES). R. Levato and J. Malda received funding from the Dutch Arthritis Foundation, and J. Malda received funding from the European Research Council under Grant Agreement No. 647426 (3D-JOINT). L. J. Bonassar received funding from Histogenics, Inc., 3D BioCorp, Inc., General Electric, Inc., New York State Advanced Research Fund, and NIH F31AR064695-01. D. D. D’Lima received funding from the National Institutes of Health (P01 AG007996), the California Institute of Regenerative Medicine (PC1-08128), and the Shaffer Family Foundation. D. Grande received funding from the Lora and Craig Treiber Family Foundation, American Foundation for Surgery of the Hand, and the Department of Orthopedic Surgery Northwell Health System. T. Klein received funding from the Australian Research Council (FT110100166) and the National Health and Medical Research Council (1067108). M. Zenobi-Wong received funding from the Swiss National Science Foundation (CR32I3_146338).
Publisher Copyright:
© 2016, © The Author(s) 2016.
PY - 2017/10/1
Y1 - 2017/10/1
N2 - Three-dimensional (3D) bioprinting techniques can be used for the fabrication of personalized, regenerative constructs for tissue repair. The current article provides insight into the potential and opportunities of 3D bioprinting for the fabrication of cartilage regenerative constructs. Although 3D printing is already used in the orthopedic clinic, the shift toward 3D bioprinting has not yet occurred. We believe that this shift will provide an important step forward in the field of cartilage regeneration. Three-dimensional bioprinting techniques allow incorporation of cells and biological cues during the manufacturing process, to generate biologically active implants. The outer shape of the construct can be personalized based on clinical images of the patient’s defect. Additionally, by printing with multiple bio-inks, osteochondral or zonally organized constructs can be generated. Relevant mechanical properties can be obtained by hybrid printing with thermoplastic polymers and hydrogels, as well as by the incorporation of electrospun meshes in hydrogels. Finally, bioprinting techniques contribute to the automation of the implant production process, reducing the infection risk. To prompt the shift from nonliving implants toward living 3D bioprinted cartilage constructs in the clinic, some challenges need to be addressed. The bio-inks and required cartilage construct architecture need to be further optimized. The bio-ink and printing process need to meet the sterility requirements for implantation. Finally, standards are essential to ensure a reproducible quality of the 3D printed constructs. Once these challenges are addressed, 3D bioprinted living articular cartilage implants may find their way into daily clinical practice.
AB - Three-dimensional (3D) bioprinting techniques can be used for the fabrication of personalized, regenerative constructs for tissue repair. The current article provides insight into the potential and opportunities of 3D bioprinting for the fabrication of cartilage regenerative constructs. Although 3D printing is already used in the orthopedic clinic, the shift toward 3D bioprinting has not yet occurred. We believe that this shift will provide an important step forward in the field of cartilage regeneration. Three-dimensional bioprinting techniques allow incorporation of cells and biological cues during the manufacturing process, to generate biologically active implants. The outer shape of the construct can be personalized based on clinical images of the patient’s defect. Additionally, by printing with multiple bio-inks, osteochondral or zonally organized constructs can be generated. Relevant mechanical properties can be obtained by hybrid printing with thermoplastic polymers and hydrogels, as well as by the incorporation of electrospun meshes in hydrogels. Finally, bioprinting techniques contribute to the automation of the implant production process, reducing the infection risk. To prompt the shift from nonliving implants toward living 3D bioprinted cartilage constructs in the clinic, some challenges need to be addressed. The bio-inks and required cartilage construct architecture need to be further optimized. The bio-ink and printing process need to meet the sterility requirements for implantation. Finally, standards are essential to ensure a reproducible quality of the 3D printed constructs. Once these challenges are addressed, 3D bioprinted living articular cartilage implants may find their way into daily clinical practice.
KW - Additive manufacturing (AM)
KW - Bio-ink
KW - Bioprinting
KW - Regenerative medicine
KW - n/a OA procedure
UR - http://www.scopus.com/inward/record.url?scp=85029816807&partnerID=8YFLogxK
U2 - 10.1177/1947603516665445
DO - 10.1177/1947603516665445
M3 - Review article
C2 - 28934880
SN - 1947-6035
VL - 8
SP - 327
EP - 340
JO - Cartilage
JF - Cartilage
IS - 4
ER -